Purchases and Sales Made in Q1 2022 in Moon Lake Immunotherapeutics (MLTX)
This table provides information about the institutional ownership of Moon Lake Immunotherapeutics (MLTX) during Q1 2022. The information is specifically focused on institutions that hold shares of MoonLake Immunotherapeutics.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 16, 2022
Q1 2022
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
654KNew |
$6.18M - $7.26M
|
654K
$35.6M
|